Regulatory action deals with subset of $1.8 million misappropriation
Triple the proceeds of misconduct deemed more adequate deterrent
U.S. authorities allege biostatistician traded on cancer drug data
Concerns about company were raised by short sellers in 2022
Former rep traded investors' discount brokerage accounts for them
Regulator settled with Rio Tinto, former CEO in 2023
Courts awards plaintiffs' costs, criticizes effort to force foreign arbitration
Former senior executive pleaded guilty to trading ahead of deteriorating results
Adjudicator rejects $213M claim against Bridging flagship fund
Investors lost $9.8M on investment that turned out to be a fraud